Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 075270

Expand all

KETOPROFEN (KETOPROFEN)
100MG
Marketing Status: Discontinued

Active Ingredient: KETOPROFEN
Proprietary Name: KETOPROFEN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075270
Product Number: 002
Approval Date: Mar 24, 1999
Applicant Holder Full Name: ACTAVIS LABORATORIES FL INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

KETOPROFEN (KETOPROFEN)
150MG
Marketing Status: Discontinued

Active Ingredient: KETOPROFEN
Proprietary Name: KETOPROFEN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075270
Product Number: 003
Approval Date: Mar 24, 1999
Applicant Holder Full Name: ACTAVIS LABORATORIES FL INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

KETOPROFEN (KETOPROFEN)
200MG
Marketing Status: Discontinued

Active Ingredient: KETOPROFEN
Proprietary Name: KETOPROFEN
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075270
Product Number: 001
Approval Date: Mar 24, 1999
Applicant Holder Full Name: ACTAVIS LABORATORIES FL INC
Marketing Status:  Discontinued
Patent and Exclusivity Information